-
661
On the critical periods of Liénard systems with cubic restoring forces
Published 2004-01-01Get full text
Article -
662
Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer
Published 2025-01-01Get full text
Article -
663
Two-Party Quantum Private Comparison Protocol for Direct Secret Comparison
Published 2025-01-01Get full text
Article -
664
-
665
Two-Party Quantum Private Comparison Protocol Based on Rotational Encryption
Published 2025-01-01Get full text
Article -
666
Evaluation of safe bearing capacity of soil foundation by using numerical analysis method
Published 2014-10-01Get full text
Article -
667
Factors Affecting the Mechanical Properties of Cement-Mixed Gravel
Published 2016-01-01Get full text
Article -
668
Quantitative Detection of Financial Fraud Based on Deep Learning with Combination of E-Commerce Big Data
Published 2020-01-01Get full text
Article -
669
The Incentive Model in Supply Chain with Trade Credit and Default Risk
Published 2019-01-01Get full text
Article -
670
An Iterative Algorithm for the Generalized Reflexive Solution of the Matrix Equations AXB=E, CXD=F
Published 2012-01-01Get full text
Article -
671
Resolvent Positive Operators and Positive Fractional Resolvent Families
Published 2021-01-01Get full text
Article -
672
-
673
-
674
The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
Published 2025-01-01Get full text
Article -
675
-
676
Glioblastoma-derived migrasomes promote migration and invasion by releasing PAK4 and LAMA4
Published 2025-01-01Get full text
Article -
677
-
678
-
679
-
680
Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial
Published 2025-01-01“…Yixian Liu,1,2,* Xiaoyu Li,1,2,* Mengyu Zhang,1,2 Yuchun Men,1,2 Ying Wang,1,2 Xiaohong Zhu,1,2 Li Zheng1,2 1Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 2Clinical Trial Center, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China*These authors contributed equally to this workCorrespondence: Li Zheng, Cancer Center, West China Hospital, Sichuan University, No. 5 Telecom Road, Wuhou District, Chengdu, 610041, People’s Republic of China, Email zhengli@wchscu.cnPurpose: HA121-28, a novel multi-targeting tyrosine kinase inhibitor, has dual efficacy against tumor growth and neovascularization. …”
Get full text
Article